A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission
Only modest advances in AML therapy have occurred in the past decade and relapse due to residual disease remains the major challenge. The potential of the immune system to address this is evident in the success of allogeneic transplantation, however this leads to considerable morbidity. Dendritic ce...
Main Authors: | Jennifer L. Hsu, Christian E. Bryant, Michael S. Papadimitrious, Benjamin Kong, Robin E. Gasiorowski, Daniel Orellana, Helen M. McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, P. Joy Ho, Stephen Larsen, Harry J. Iland, John Gibson, Georgina J. Clark, Phillip D. Fromm, Derek NJ Hart |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-04-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1419114 |
Similar Items
-
Implementing a Feasible Exercise Programme in an Allogeneic Haematopoietic Stem Cell Transplantation Setting—Impact on Physical Activity and Fatigue
by: Annika Kisch, et al.
Published: (2020-06-01) -
Single-centre experience of allogeneic haemopoietic stem cell transplant in paediatric patients in Cape Town, South Africa
by: A van Eyssen, et al.
Published: (2017-03-01) -
High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft
by: Nicolas Stocker, et al.
Published: (2020-01-01) -
Acute abdomen after allogenic haematopoietic stem cell transplantation
by: Alessandro Crocoli, et al.
Published: (2011-06-01) -
SEVERE (GRADE III-IV) ACUTE GRAFT VERSUS HOST DISEASE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Irena Preložnik-Zupan, et al.
Published: (2002-09-01)